Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – The incidence of non-Hodgkin’s lymphoma (NHL) is increased somewhat in patients with diabetes, according to results of a meta-analysis published in Diabetes Care…
NEW YORK (Reuters Health) – The results of a case-control study suggest that the benefit of colonoscopy in preventing colorectal cancer deaths is largely limited to left-sided malignancies.…
NEW YORK (Reuters Health) – Results of a phase I trial suggest that intralesional transfer of plasmid interleukin (IL)-12 enhanced by electroporation for treatment of metastatic melanoma is…
NEW YORK (Reuters Health) – While prophylactic cranial irradiation can reduce the occurrence of brain metastases and improve survival in patients treated for extensive-disease small-cell lung cancer, it…
NEW YORK (Reuters Health) – In patients with resectable cancer of the pancreas, the use of neoadjuvant radiation therapy over surgery alone or surgery plus postoperative radiation therapy…
By Megan Rauscher NEW YORK (Reuters Health) – Among US Latinas, a greater degree of European genetic ancestry is associated with increased breast cancer risk, results of a…
NEW YORK (Reuters Health) – The results of a new study reaffirm the importance of treating heterozygous familial hypercholesterolemia (FH) with statins, linking therapy with reductions in all-cause,…
NEW YORK (Reuters Health) – A brief discussion among members of the operating room team just before surgery begins to outline the procedure and review important components can…
NEW YORK (Reuters Health) – The incidence of venous thromboembolism in patients with advanced cancer is increased by about 33% during treatment with the angiogenesis inhibitor bevacizumab, the…
NEW YORK (Reuters Health) – A history of migraine is strongly associated with reduced risk of hormone receptor-positive invasive breast cancer among postmenopausal women, according to findings from…
